Time course of development of the antihypertensive effect of propranolol.
- 1 November 1983
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 5 (6) , 852-857
- https://doi.org/10.1161/01.hyp.5.6.852
Abstract
Ten patients with essential hypertension were hospitalized and treated with placebo, followed by their usual dose of propranolol. Systolic and diastolic blood pressure decreased significantly after the first dose of propranolol, and by the third day of propranolol treatment reached 84% to 92% of the maximum decrease achieved during the 6 days of treatment. Mean maximum falls in blood pressure were 13/12 mm Hg supine and 12/13 mm Hg standing. This development of the decrease in heart rate and blood pressure over 48 hours occurred in parallel with cumulation of propranolol to steady state in plasma. The decrease in diastolic, but not systolic, arterial pressure was directly related to pretreatment blood pressure, but not significantly related to pretreatment plasma renin activity (PRA) or change in PRA. Thus, single doses of propranolol lowered blood pressure in patients with essential hypertension, and with continued therapy, near maximum antihypertensive effects were achieved within 48 hours.This publication has 11 references indexed in Scilit:
- Time course of blood pressure, pulse rate, plasma renin and metoprolol during treatment of hypertensive patientsEuropean Journal of Clinical Pharmacology, 1980
- 4-Hydroxypropranolol and its glucuronide after single and long-term doses of propranololClinical Pharmacology & Therapeutics, 1979
- Clinical Pharmacokinetics of PropranololClinical Pharmacokinetics, 1979
- The predictable relationship between plasma levels and dose during chronic propranolol therapyClinical Pharmacology & Therapeutics, 1978
- Pharmacodynamics of minoxidil as a guide for individualizing dosage regimens in hypertensionClinical Pharmacology & Therapeutics, 1975
- β-Adrenergic Blockade in Diuretic-Treated Patients with Essential HypertensionNew England Journal of Medicine, 1975
- Disposition of propranolol VI. Independent variation in steady‐state circulating drug concentrations and half‐life as a result of plasma drug binding in manClinical Pharmacology & Therapeutics, 1973
- Propranolol Inhibition of Renin SecretionNew England Journal of Medicine, 1972
- Radioimmunoassay of Angiotensin I: Comparison of Two Renin Activity Methods and Use for Other Measurements of the Renin SystemClinical Chemistry, 1972
- Propranolol in hypertensionThe American Journal of Cardiology, 1966